Announcements Trials

Browse Landscape

Phase

Status

Unknown 19 Completed 10 Not yet recruiting 6 Recruiting 3 Enrolling by invitation 2 Active not recruiting 1

Sponsor Class

OTHER 96 INDUSTRY 31 NIH 16 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 18 Gastrointestinal 17 Gynecologic 11 Genitourinary 7 Lymphoid 6 Head & Neck 5 Thoracic 4 Plasma cell 2 Other hematologic neoplasm 2 Tumor-Agnostic 1 Other neoplasm 1 Other 1 Myeloid 1 Endocrine 1 Dermatologic 1

Conditions

Adrenocortical Carcinoma 1

Interventions

pembrolizumab 1 lenvatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER_GOV × Endocrine × Clear all

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡